Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
recent articles
Samsung Medical Center has demonstrated the most comprehensive use of an integrated digital pathology to date. Given a rapidly aging population and an overwhelmed health system, hospitals like Samsung Medical Center had to deal with rising...
Deep Bio: USCAP 2023 is sixth consecutive year of presenting research abstracts SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three...
March 2, 2023 - Visiopharm, a leading provider of AI-driven precision pathology software, has announced the launch of a next-generation Ki67 algorithm providing diagnostic decision support for pathologists. The algorithm, which has been cleared...
Budapest, 23 March 2023 – Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop...
Though still in trials, early results show tests may be more accurate than traditional clinical laboratory tests for detecting prostate cancer Within weeks of each other, different research teams in the US and UK published findings of their...
Concord, MA and Singapore, March 12, 2023 – Corista, a leading provider of clinical, research and educational digital pathology image management solutions, and Qritive, a leading developer of artificial intelligence (AI)-powered cancer...
